This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Mar;82(3):733-736.

doi: 10.1016/j.jaad.2019.02.029. Epub 2019 Feb 18.

Systemic timolol exposure following topical application to infantile hemangiomas

Beth A Drolet¹, Felix Boakye-Agyeman², Barrie Harper², Kristen Holland³, Andrew Lewandowski⁴, Nicole Stefanko³, Chiara Melloni²; Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.)

Collaborators, Affiliations

Collaborators

Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.):
Gary Furda, Danny Benjamin, Edmund Capparelli, Gregory L Kearns, Ian M Paul, Christoph Hornik, Kelly Wade

Affiliations

¹ Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: bdrolet@dermatolgy.wisc.edu.
² Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
³ Medical College of Wisconsin, Milwaukee, Wisconsin.
⁴ The Emmes Corporation, Rockville, Maryland.

PMID: 30790601
DOI: 10.1016/j.jaad.2019.02.029

Systemic timolol exposure following topical application to infantile hemangiomas

Beth A Drolet et al. J Am Acad Dermatol. 2020 Mar.

. 2020 Mar;82(3):733-736.

doi: 10.1016/j.jaad.2019.02.029. Epub 2019 Feb 18.

Authors

Beth A Drolet¹, Felix Boakye-Agyeman², Barrie Harper², Kristen Holland³, Andrew Lewandowski⁴, Nicole Stefanko³, Chiara Melloni²; Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.)

Collaborators

Pediatric Trials Network Steering Committee (See Acknowledgments for a listing of committee members.):
Gary Furda, Danny Benjamin, Edmund Capparelli, Gregory L Kearns, Ian M Paul, Christoph Hornik, Kelly Wade

Affiliations

¹ Medical College of Wisconsin, Milwaukee, Wisconsin. Electronic address: bdrolet@dermatolgy.wisc.edu.
² Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
³ Medical College of Wisconsin, Milwaukee, Wisconsin.
⁴ The Emmes Corporation, Rockville, Maryland.

PMID: 30790601
DOI: 10.1016/j.jaad.2019.02.029

No abstract available

PubMed Disclaimer

Similar articles

Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution.
Rizvi SA, Yusuf F, Sharma R, Rizvi SW. Rizvi SA, et al. Semin Ophthalmol. 2015 Jan;30(1):62-4. doi: 10.3109/08820538.2013.821505. Epub 2013 Sep 27. Semin Ophthalmol. 2015. PMID: 24074395
Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas.
Painter SL, Hildebrand GD. Painter SL, et al. J AAPOS. 2016 Apr;20(2):172-174.e1. doi: 10.1016/j.jaapos.2015.11.012. J AAPOS. 2016. PMID: 27079600
Topical timolol treatment for periocular infantile haemangioma in the developing world.
Jefferson RJ, Hildebrand GD. Jefferson RJ, et al. Trop Doct. 2019 Jul;49(3):246-248. doi: 10.1177/0049475519843411. Epub 2019 Apr 23. Trop Doct. 2019. PMID: 31014195
Review of topical beta blockers as treatment for infantile hemangiomas.
Painter SL, Hildebrand GD. Painter SL, et al. Surv Ophthalmol. 2016 Jan-Feb;61(1):51-8. doi: 10.1016/j.survophthal.2015.08.006. Epub 2015 Sep 25. Surv Ophthalmol. 2016. PMID: 26408055 Review.
Current concepts in the management of periocular infantile (capillary) hemangioma.
Ni N, Guo S, Langer P. Ni N, et al. Curr Opin Ophthalmol. 2011 Sep;22(5):419-25. doi: 10.1097/ICU.0b013e32834994b4. Curr Opin Ophthalmol. 2011. PMID: 21730838 Review.

See all similar articles

Cited by

Pediatric Hemangiomas in the Female Genital Tract: A Literature Review.
Merlino L, Volpicelli AI, Anglana F, D'Ovidio G, Dominoni M, Pasquali MF, Gardella B, Inghirami P, Lippa P, Senatori R. Merlino L, et al. Diseases. 2024 Feb 28;12(3):48. doi: 10.3390/diseases12030048. Diseases. 2024. PMID: 38534972 Free PMC article. Review.
Hyperkalemia due to topical timolol for hemangioma.
Alasmari B, Alkhenaizan A, Al-Khenaizan S. Alasmari B, et al. JAAD Case Rep. 2023 Jul 17;39:53-54. doi: 10.1016/j.jdcr.2023.07.006. eCollection 2023 Sep. JAAD Case Rep. 2023. PMID: 37583838 Free PMC article. No abstract available.
Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas.
Chang SJ, Wang H, Chen J, Chen Q, Chang L, Huang Y, Qiu Y, Lin X. Chang SJ, et al. Pharmaceutics. 2022 Aug 1;14(8):1607. doi: 10.3390/pharmaceutics14081607. Pharmaceutics. 2022. PMID: 36015233 Free PMC article.
Medical Management of Infantile Hemangiomas: An Update.
Colmant C, Powell J. Colmant C, et al. Paediatr Drugs. 2022 Jan;24(1):29-43. doi: 10.1007/s40272-021-00477-9. Epub 2021 Oct 22. Paediatr Drugs. 2022. PMID: 34677814 Review.
Paediatrics: how to manage infantile haemangioma.
Kim JH, Lam JM. Kim JH, et al. Drugs Context. 2021 Apr 6;10:2020-12-6. doi: 10.7573/dic.2020-12-6. eCollection 2021. Drugs Context. 2021. PMID: 33889196 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources